APLS
NASDAQ HealthcareApellis Pharmaceuticals, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $18.39 |
|---|---|
| Volume | 2,597,891 |
| Market Cap | 2.35B |
| Beta | 0.290 |
| RSI (14-Day) | 13.2 Oversold |
| 200-Day MA | $22.47 |
| 50-Day MA | $22.21 |
| 52-Week High | $30.48 |
| 52-Week Low | $16.10 |
| P/E Ratio | 102.17 |
| Forward P/E | -75.68 |
| Price / Book | 6.29 |
🎯 Investment Strategy Scores
How APLS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
47/100
High dividend yield + low volatility
🚀 Moon Shot
41/100
High growth potential (high beta + oversold)
🔪 Falling Knife
91/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
4/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
43/100
Large-cap, institutional-quality stocks
Find APLS in your text
Paste any text on the homepage — the tool will extract APLS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.